UPDATE - Citi Downgrades Gilead Sciences (GILD) to Hold; HIV Trends Decelerating in U.S. - No Near-Term Catalysts

Go back to UPDATE - Citi Downgrades Gilead Sciences (GILD) to Hold; HIV Trends Decelerating in U.S. - No Near-Term Catalysts
Gilead Sciences (NASDAQ: GILD) Delayed: 130.21 -1.07 (0.82%)
Previous Close $131.28    52 Week High $108.63 
Open $130.23    52 Week Low $71.39 
Day High $130.89    P/E 71.94 
Day Low $128.76    EPS $1.81 
Volume 6,531,643